Search results for "Adverse Events"


 
Results 1 - 10 of about 516 for "Adverse Events".
Sort by: Relevance | Newest | Oldest

Corticosteroids may prevent need for mechanical ventilation in CAP patients, review finds

The meta-analysis did not find any significant effect of steroids on other studied outcomes, including mortality, treatment failure, and adverse events, in trials of patients with community-acquired pneumonia (CAP).
https://acphospitalist.acponline.org/archives/2022/09/14/corticosteroids-may-prevent-need-for-mechanical-ventilation-in-cap-patients-review-finds.htm
14 Sep 2022

Acetazolamide improved decongestion in acute decompensated heart failure

A randomized trial found that the drug, already approved for other indications, achieved successful decongestion within three days in 42.2% of acute decompensated heart failure patients, compared to 30.5% of those on placebo.
https://acphospitalist.acponline.org/archives/2022/08/31/acetazolamide-improved-decongestion-in-acute-decompensated-heart-failure.htm
31 Aug 2022

Electronic tool for ICU-to-ward discharge linked to timely, complete discharge summaries

A Canadian study of adult patients discharged from the ICU to a hospital ward found that the proportion of those with timely and complete discharge summaries increased from 10.8% to 71.1% after implementation of a structured electronic discharge summary tool.
https://acphospitalist.acponline.org/archives/2022/08/24/electronic-tool-for-icu-to-ward-discharge-linked-to-timely-complete-discharge-summaries.htm
24 Aug 2022

Patients treated for syncope have similar motor vehicle crash risk as other ED patients

Patients treated in an ED for syncope had a crash rate of 12.2 per 100 driver-years, compared to 13.2 in patients treated in the ED for other conditions and 8.2 in the general population, a retrospective study in Canada found.
https://acphospitalist.acponline.org/archives/2022/08/03/patients-treated-for-syncope-have-similar-motor-vehicle-crash-risk-as-other-ed-patients.htm
3 Aug 2022

Procalcitonin algorithm reduced antibiotic use in patients with acute pancreatitis

A randomized trial assigned some patients to a treatment strategy of starting, stopping, or continuing antibiotics based on whether their procalcitonin test value was more or less than 1.0 ng/mL.
https://acphospitalist.acponline.org/archives/2022/07/27/procalcitonin-algorithm-reduced-antibiotic-use-in-patients-with-acute-pancreatitis.htm
27 Jul 2022

Inpatient adverse event rates declined from 2010 to 2019

An analysis of U.S. hospitals found significant decreases in adverse event rates among patients hospitalized for acute myocardial infarction, heart failure, pneumonia, or major surgical procedures.
https://acphospitalist.acponline.org/archives/2022/07/20/inpatient-adverse-event-rates-declined-from-2010-to-2019.htm
20 Jul 2022

COVID-19 stalls progress made against antimicrobial resistance in U.S.

Antimicrobial-resistant infections and deaths related to hospitalization both increased by at least 15% during the first year of the pandemic, according to a recent CDC report.
https://acphospitalist.acponline.org/archives/2022/07/20/free/covid-19-stalls-progress-made-against-antimicrobial-resistance-in-us.htm
20 Jul 2022

LMWH may offer best risk-benefit profile for thromboprophylaxis in medical inpatients

A meta-analysis found that an intermediate dose of low-molecular-weight heparin (LMWH) had the most favorable balance of risk and harms during hospitalization for acute illness, while unfractionated heparin and direct oral anticoagulants had the least.
https://acphospitalist.acponline.org/archives/2022/07/13/lmwh-may-offer-best-risk-benefit-profile-for-thromboprophylaxis-in-medical-inpatients.htm
13 Jul 2022

Advisors discuss vaccines for fall, COVID-19/RSV/flu test approved

In addition to COVID-19-related actions, the FDA announced several device recalls and approved a drug for eosinophilic esophagitis.
https://acphospitalist.acponline.org/archives/2022/07/06/advisors-discuss-vaccines-for-fall-covid-19-rsv-flu-test-approved.htm
6 Jul 2022

New studies find no benefit to vitamin C or fluid restriction in sepsis

One international trial found higher 28-day mortality in ICU patients randomized to a vitamin C infusion compared to placebo, while another showed that 90-day mortality rates were similar when septic shock patients were treated with a standard or restrictive IV fluid strategy.
https://acphospitalist.acponline.org/archives/2022/06/22/free/new-studies-find-no-benefit-to-vitamin-c-or-fluid-restriction-in-sepsis.htm
22 Jun 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next